Mr. Ian Scott:

I will lead off with the question about how vets are addressing antiparasitic resistance. As a quick example, a sheep wormer called Zolvix was launched about nine years ago. It contained a brand new anthelmintic as its active ingredient and there had not been a brand new one in 25 years. It is currently sold only by vets - it is under vet control - but the uptake of it, which has no known resistance and a very simple user message, is less than 100 l per year. If vets are addressing antiparasitic resistance effectively, why is the only non-resistant sheep wormer on the market not being used in greater quantities? I will put that on the table for the committee to think about.